The challenges facing healthcare are tremendous. They include sharply increasing cost and demand, combined with a shortage of primary-care providers and widespread budget cuts. And yet, Lucien Engelen argues, the system is moving too slowly toward the only real solution: inviting patients to take a more active role in their own care.
All posts in Advisory Board Profiles
Susannah Fox: In survey data, watching web and healthcare culture shift
In 2002, Susannah Fox and her colleagues at the Pew Internet & American Life Project first identified “the broadband difference.”
They discovered, through simple phone surveys, that people with access to high-speed connections took part in about seven online activities each day, whereas their counterparts subjected to the beeps and buzzes of a dial-up wait took part in only three. Unsurprisingly, those who faced lower barriers to use were more likely to turn to the web to answer questions or solve problems.
Scott Klemmer on the power of naïveté
Medicine X is looking forward to uniting a wide variety of experience and talent this September. Not sure how you’d fit in? Consider this, a Q&A with advisory board member Scott Klemmer, your call to action.
European perspectives on eHealth: a Q&A with Denise Silber
Denise Silber is the founder and president of Basil Strategies, a Paris-based healthcare emarketing and social media consultancy. She’s recognized for her pioneering work in linking the European and American medical communities online, for which she was decorated with the French Legion of Honor in 2011. Today, she’s busy putting together the second annual Doctors 2.0 & You conference, which will convene May 23 and 24 in Paris.
Amy Tenderich, founder of Diabetes Mine, on thinking like a patient
A few months after Novo Nordisk gained FDA approval for its type-2 diabetes drug, Victoza, in January of 2010, Amy Tenderich sat down to write a review of the product on her blog, Diabetesmine.com. She quickly covered the drug’s vital stats—Victoza is an injectable glucagon-like peptide-1 designed to stimulate insulin secretion when high blood sugar is present—and then moved on to address the questions she knew would concern potential users: What type of patient would it benefit? How did it stack up against its competitor, Byetta? What were its side effects? What were its potential risks? What would happen when users combined Victoza with their usual oral anti-diabetes drugs?
Continue Reading →
Medicine X Blog
SEPTEMBER 27-29, 2013
Medicine X is a catalyst for new ideas about the future of medicine and health care. The Medicine X initiative is designed to explore the potential of social media and information technology to advance the practice of medicine, improve health, and empower patients to be active participants in their own care. The “X” is meant to evoke a move beyond numbers and trends—it represents the infinite possibilities for current and future information technologies to improve health.
Medicine X is a catalyst for new ideas about the future of medicine and health care. The Medicine X initiative is designed to explore the potential of social media and information technology to advance the practice of medicine, improve health, and empower patients to be active participants in their own care. The “X” is meant to evoke a move beyond numbers and trends—it represents the infinite possibilities for current and future information technologies to improve health.
Join our growing network today and keep posted on the latest news and progress about Stanford Medicine X!
RSS FEED
Latest Comments